| 1 |
Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial
John P. O’Reardon, H. Brent Solvason, Philip G. Janicak et al. · Biological Psychiatry
|
31 Jul 2007 |
1,941 |
| 2 |
TRANSCRANIAL MAGNETIC STIMULATION (TMS) FOR MAJOR DEPRESSION: A MULTISITE, NATURALISTIC, OBSERVATIONAL STUDY OF ACUTE TREATMENT OUTCOMES IN CLINICAL PRACTICE
Linda L. Carpenter, Philip G. Janicak, Scott T. Aaronson et al. · Depression and Anxiety
|
11 Jun 2012 |
372 |
| 3 |
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial
Michael J. Detke, Curtis G. Wiltse, Craig H. Mallinckrodt et al. · European Neuropsychopharmacology
|
16 Mar 2004 |
285 |
| 4 |
The Risk of Switch to Mania in Patients With Bipolar Disorder During Treatment With an Antidepressant Alone and in Combination With a Mood Stabilizer
Alexander Viktorin, Paul Lichtenstein, Michael E. Thase et al. · American Journal of Psychiatry
Open access |
17 Jun 2014 |
250 |
| 5 |
Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder
Philip G. Janicak, John P. O’Reardon, Shirlene M. Sampson et al. · The Journal of Clinical Psychiatry
|
15 Feb 2008 |
237 |
| 6 |
Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome
Leslie J. Crofford, Elizabeth A. Young, N. Cary Engleberg et al. · Brain Behavior and Immunity
|
27 Feb 2004 |
233 |
| 7 |
Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation
Harold A. Sackeïm, Scott T. Aaronson, Linda L. Carpenter et al. · Journal of Affective Disorders
Open access |
7 Aug 2020 |
202 |
| 8 |
Low-Dose Recombinant Tissue-Type Plasminogen Activator Enhances Clot Resolution in Brain Hemorrhage
Neal J. Naff, Michael Allen Williams, Penelope M. Keyl et al. · Stroke
Open access |
25 Aug 2011 |
176 |
| 9 |
Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study
Philip G. Janicak, Ziad H. Nahas, Sarah Hollingsworth Lisanby et al. · Brain stimulation
Open access |
12 Aug 2010 |
170 |
| 10 |
The bouba/kiki effect is robust across cultures and writing systems
Aleksandra Ćwiek et al. · Philosophical Transactions of the Royal Society B Biological Sciences
Open access |
15 Nov 2021 |
169 |
| 11 |
Left prefrontal transcranial magnetic stimulation for treatment-resistant depression in adolescents: a double-blind, randomized, sham-controlled trial
Paul E. Croarkin, Ahmed Z. Elmaadawi, Scott T. Aaronson et al. · Neuropsychopharmacology
Open access |
12 Sep 2020 |
134 |
| 12 |
Transcranial Magnetic Stimulation in the Acute Treatment of Major Depressive Disorder
David Avery, K E Isenberg, Shirlene M. Sampson et al. · The Journal of Clinical Psychiatry
|
15 Mar 2008 |
131 |
| 13 |
Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research
Lindsay M. Oberman, Peter G. Enticott, Manuel Fernando Casanova et al. · Autism Research
Open access |
4 Nov 2015 |
114 |
| 14 |
Curcuma longa Extract Protects against Gastric Ulcers by Blocking H2 Histamine Receptors
Dong Chan Kim, Sun-Hee Kim, Bo-Hwa Choi et al. · Biological and Pharmaceutical Bulletin
Open access |
2005 |
98 |
| 15 |
Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis
Kit N. Simpson, Mary Jane Welch, Frank Andrew Kozel et al. · Advances in Therapy
|
Mar 2009 |
96 |
| 16 |
Human adult bone marrow-derived somatic cells rescue vision in a rodent model of retinal degeneration
Bin Lü, S. Wang, Sergey Girman et al. · Experimental Eye Research
|
6 Jul 2010 |
95 |
| 17 |
The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
Jared Cooney Horvath, John Mathews, Mark A. Demitrack et al. · Journal of Visualized Experiments
Open access |
12 Nov 2010 |
83 |
| 18 |
Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study
Noah S. Philip, David L. Dünner, Sheila M. Dowd et al. · Brain stimulation
Open access |
25 Nov 2015 |
80 |
| 19 |
Comparison of clinical outcomes with two Transcranial Magnetic Stimulation treatment protocols for major depressive disorder
LindaL. Carpenter, ScottT. Aaronson, Todd M. Hutton et al. · Brain stimulation
Open access |
18 Dec 2020 |
60 |
| 20 |
Suppressing the Surface Field During Transcranial Magnetic Stimulation
KENT R. DAVEY, Mark Riehl · IEEE Transactions on Biomedical Engineering
|
25 Jan 2006 |
60 |
| 21 |
Comparison of clinical outcomes with left unilateral and sequential bilateral Transcranial Magnetic Stimulation (TMS) treatment of major depressive disorder in a large patient registry
Scott T. Aaronson, Linda L. Carpenter, Todd M. Hutton et al. · Brain stimulation
Open access |
22 Jan 2022 |
51 |
| 22 |
Improvement in Quality of Life With Left Prefrontal Transcranial Magnetic Stimulation in Patients With Pharmacoresistant Major Depression: Acute and Six Month Outcomes
H. Brent Solvason, Mustafa M. Husain, Paul Bernard Fitzgerald et al. · Brain stimulation
Open access |
4 Nov 2013 |
48 |
| 23 |
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice
Philip G. Janicak, David L. Dünner, Scott T. Aaronson et al. · CNS Spectrums
Open access |
30 Jul 2013 |
44 |
| 24 |
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
Mark A. Demitrack, Michael E. Thase · Psychopharmacology Bulletin
|
12 Aug 2025 |
43 |
| 25 |
Designing transcranial magnetic stimulation systems
KENT R. DAVEY, Mark Riehl · IEEE Transactions on Magnetics
|
Mar 2005 |
40 |
| 26 |
Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): Sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder
Peter B. Rosenquist, Andrew D. Krystal, Karen L. Heart et al. · Psychiatry Research
|
26 Sep 2012 |
38 |
| 27 |
A Double-blind, Placebo-Controlled Study of the Impact of Galantamine on Anterograde Memory Impairment During Electroconvulsive Therapy
John Matthews, Caleb J. Siefert, Mark A. Blais et al. · Journal of Ect
|
22 Mar 2013 |
34 |
| 28 |
Linking disease symptoms and subtypes with personalized systems-based phenotypes: A proof of concept study
Kirstin Aschbacher, Emma Kristine Adam, Leslie J. Crofford et al. · Brain Behavior and Immunity
Open access |
9 Jun 2012 |
33 |
| 29 |
Treatment-Resistant Depression in Adolescents: Clinical Features and Measurement of Treatment Resistance
Jeffrey Robert Strawn, Scott T. Aaronson, Ahmed Z. Elmaadawi et al. · Journal of Child and Adolescent Psychopharmacology
Open access |
21 Apr 2020 |
20 |
| 30 |
Effectiveness of NeuroStar transcranial magnetic stimulation (TMS) in patients with major depressive disorder with postpartum onset
David G. Brock, Mark A. Demitrack, Pashia Groom et al. · Brain stimulation
Open access |
27 Aug 2016 |
20 |
| 31 |
Neurosensory Symptom Complexes after Acute Mild Traumatic Brain Injury
Michael E. Hoffer, Mikhaylo Szczupak, Alexander Kiderman et al. · PLoS ONE
Open access |
4 Jan 2016 |
20 |
| 32 |
Treatment-Resistant Depression
Philip G. Janicak, Sheila M. Dowd · Psychopharm Review
|
Jun 2009 |
17 |
| 33 |
Preparation and characterization of stable phospholipid–silica nanostructures loaded with quantum dots
Natalia V. Beloglazova, Irina Yu. Goryacheva, ПАВЕЛ СЕРГЕЕВИЧ ШМЕЛИН et al. · Journal of Materials Chemistry B
|
21 Nov 2014 |
16 |
| 34 |
The dynamics of indexical information in speech: Can recognizability be controlled by the speaker?
Volker Dellwo, Elisa Pellegrino, Lei He et al. · AUC PHILOLOGICA
Open access |
18 Oct 2019 |
7 |
| 35 |
The Use and Clinical Significance of Transcranial Magnetic Stimulation in the Treatment of Major Depression
Mark A. Demitrack · Psychopharm Review
|
Jun 2007 |
7 |
| 36 |
Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary
Mark A. Demitrack · Pharmacogenomics
|
Apr 2006 |
5 |
| 37 |
A Multisite, 6-Month, Open-Label Study of Maintenance Transcranial Magnetic Stimulation for Adolescents with Treatment-Resistant Depression
Juan Felipe Garzon, Ahmed Z. Elmaadawi, Scott T. Aaronson et al. · Journal of Child and Adolescent Psychopharmacology
Open access |
24 Dec 2024 |
4 |
| 38 |
Transcranial Magnetic Stimulation for the Treatment of Major Depression
Mark A. Demitrack · Psychopharm Review
|
Apr 2010 |
4 |
| 39 |
Characterization of a Novel Human Anti-HIV-1 gp41 IgM Monoclonal Antibody Designated Clone 37
Chuanhai Cao, Yun Bai, Mary Jolene Holloway et al. · DNA and Cell Biology
|
Dec 2004 |
4 |
| 40 |
160 Optimizing TMS Treatment for Depression - The 19 Minute Dash™ Protocol
Miriam Mina, David G. Brock, Álvaro Pascual‐Leone et al. · CNS Spectrums
Open access |
Feb 2018 |
3 |
| 41 |
Asenapine
Philip G. Janicak, Jeffrey T. Rado · Psychopharm Review
|
Dec 2009 |
3 |
| 42 |
Post Marketing Rate of Seizures During Transcranial Magnetic Stimulation (TMS) Treatment with NeuroStar Advanced Therapy Is Lower Than Previously Estimated
Bridget A. McGugan, Karen L. Heart, David G. Brock et al. · Brain stimulation
Open access |
Nov 2020 |
2 |
| 43 |
166 Post Market Rate of Seizures During TMS Treatment with NeuroStar® System Appears to Be Lower than Previously Estimated
Paul Janicak, Karen L. Heart, Bridget A. McGugan · CNS Spectrums
Open access |
Apr 2020 |
2 |
| 44 |
Development of a Magneto-Rheological Fluid-Based Trim Actuator with Active Tactile Cueing Capabilities
Guifré Julió, Geoffrey Latham, Jean‐Sébastien Plante
Conference paper |
5 May 2015 |
2 |
| 45 |
Clinical Perspectives on Antidepressant Drug Development: A Critical Discussion
Mark A. Demitrack · Current Pharmaceutical Design
|
2005 |
2 |
| 46 |
Age is just a number: real-world effectiveness of TMS in late-life depression
Eleanor J. Cole, Scott T. Aaronson, Linda L. Carpenter et al. · Brain stimulation
Open access |
2025 |
1 |
| 47 |
Treating Schizophrenia and Bipolar I Disorder in the Real-World Setting
Maxwell Zachary Price, Richard Louis Price · The Primary Care Companion For CNS Disorders
Open access |
2 Apr 2024 |
1 |
| 48 |
Reduction of Pain-Related Symptoms with Transcranial Magnetic Stimulation (TMS) Treatment in Depressed Patients
Mark A. Demitrack, David G. Brock · Brain stimulation
|
28 Jan 2015 |
1 |
| 49 |
A Contribution to the Role of the Claustrum in Speech Motor Control Processes
Manfred Pützer, Jean Richard Moringlane, W. Reith et al. · SSRN Electronic Journal
PreprintOpen access |
2021 |
1 |
| 50 |
the Alignment Paradigm for Modeling the Self
Alexandre Pitti · HAL (Le Centre pour la Communication Scientifique Directe)
Conference paperOpen access |
2017 |
1 |